DRIO) ("DarioHealth" or "Dario"), a leading global, digital therapeutics company and member of the Digital Therapeutics Alliance (DTx), today announced its plan to present the results of a new Dario app user study at the upcoming annual conference of the American Association of Diabetes Educators (AADE) in Houston, Texas on August 9-12, 2019.
The study, which began in October 2018 and continued until April 2019, included 162 Dario app users who participated
in the Dario Coaching Program that the company offers through its digital
MyDario™ app. The digital blood-glucose and blood-pressure monitoring app
is available on iPhone or Android phones.
The results of the study demonstrate that
DarioHealth's digital therapeutic solution achieves clinically proven results
and helps improve the blood-glucose levels and overall health of users managing
Type 2 Diabetes. The results of the study also emphasize the importance of
personalized coaching interventions in helping users achieve in-range glucose
levels. Achieving and maintaining in-range glucose levels is not only a key
indicator of the efficacy of the MyDario™ app, but also an effective tool
for a user to measure how his or her body reacts to various foods, exercise and
other stimuli.
"We are excited to present our new
study at the AADE conference because the results show that well-designed
digital therapies can have a meaningful and substantial positive impact on the
health of digital app users, which is a central goal of ours," said Olivier Jarry, DarioHealth President and Chief Operating
Officer. "Our clinical results show how digital therapeutic interventions
can be an indispensable tool for individual users, employers, healthcare
providers, insurance companies and clinics to create user engagement and
improve the health outcomes of individuals with chronic illness."
No comments:
Post a Comment